Back to News
³Ô¹Ï±¬ÁÏ Partners with Sanofi to Transform
its Quality System
Leading pharmaceutical company to streamline quality processes across the enterprise
BARCELONA, Spain ¡ª 10 May 2023 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced that Sanofi is implementing ³Ô¹Ï±¬ÁÏ QMS and ³Ô¹Ï±¬ÁÏ QualityDocs to modernize quality management across the company, including consumer healthcare (CHC). As the first key milestone of Sanofi¡¯s implementation, the CHC division is now live with ³Ô¹Ï±¬ÁÏ QualityDocs and the first business processes of ³Ô¹Ï±¬ÁÏ QMS. To streamline content management and GxP training, the CHC division also selected ³Ô¹Ï±¬ÁÏ Training. The rest of Sanofi will go live over the coming year.
¡°Building a strong foundation of quality systems and processes is critical to our success,¡± said Ma?t¨¦ Durrenbach, chief quality officer at Sanofi. ¡°³Ô¹Ï±¬ÁÏ Quality Suite delivers a highly scalable enterprise solution that supports our ambition to set up a more dynamic quality operating model which is high-performing and data-driven. This will enable the Sanofi Play to Win transformation.¡±
Adopting a unified quality solution with industry best practices will advance Sanofi¡¯s broader digital transformation initiatives. With ³Ô¹Ï±¬ÁÏ Quality Suite, Sanofi will standardize quality management across all divisions and sites on a modern cloud platform.
¡°We¡¯re excited to partner with Sanofi on their quality transformation journey,¡± said Mike Jovanis, vice president, quality and manufacturing at ³Ô¹Ï±¬ÁÏ.
As the shift to digital quality gains momentum, more than 500 life sciences companies use ³Ô¹Ï±¬ÁÏ Quality applications to modernize quality management across R&D and manufacturing. To learn more about ³Ô¹Ï±¬ÁÏ Quality, visit veeva.com/eu/Quality.
Additional Information
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
About Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people¡¯s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. For more information, visit .
About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world¡¯s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
³Ô¹Ï±¬ÁÏ Forward-looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2023, which you can find (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at .
###
Contact:
Jeremy Whittaker
³Ô¹Ï±¬ÁÏ Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
Deivis Mercado
³Ô¹Ï±¬ÁÏ Systems
925-226-8821
deivis.mercado@veeva.com